NCT02145884View on ClinicalTrials.gov

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

PHASE2CompletedINTERVENTIONAL

Enrollment

26

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

October 31, 2016

Study Completion Date

November 30, 2016

Conditions

Hemangioma

Interventions

DRUG

timolol maleate 0.5% gel

Apply timolol gel 1-2 drops twice a day to lesion

Trial Locations (1)

92123

Pediatric and Adolescent Dermatology, Rady Children's Hospital/University of California, San Diego, San Diego

Sponsors

Collaborators (1)

Valeant Pharmaceuticals

All Listed Sponsors

collaborator

Valeant Pharmaceuticals

INDUSTRY

lead

Rady Children's Hospital, San Diego

OTHER

NCT02145884 - Topical Timolol Gel for the Treatment of Infantile Hemangiomas | Biotech Hunter | Biotech Hunter